MICHELLE A FANALE to Proto-Oncogene Proteins c-akt
This is a "connection" page, showing publications MICHELLE A FANALE has written about Proto-Oncogene Proteins c-akt.
Connection Strength
0.084
-
Phase II study of an AKT inhibitor MK2206 in patients with relapsed or refractory lymphoma. Br J Haematol. 2015 Nov; 171(4):463-70.
Score: 0.075
-
Combination therapy of Ad-mda7 and trastuzumab increases cell death in Her-2/neu-overexpressing breast cancer cells. Surgery. 2004 Aug; 136(2):437-42.
Score: 0.009